Literature DB >> 26462970

Prostate cancer: contouring target and organs at risk by kilovoltage and megavoltage CT and MRI in patients with and without hip prostheses.

Lorenzo Falcinelli1, Isabella Palumbo2, Valentina Radicchia2, Fabio Arcidiacono2, Valentina Lancellotta2, Giampaolo Montesi2, Fabio Matrone2, Claudio Zucchetti3, Marta Marcantonini3, Vittorio Bini4, Cynthia Aristei2.   

Abstract

OBJECTIVE: In radiotherapy treatment, planning target volume and organs at risk are contoured on kilovoltage CT (kVCT) images. Unlike MR images, kVCT does not provide precise information on target volume extension. Since neither kVCT nor MRI may be suitable for contouring in patients with ferrous hip prostheses, this study evaluated whether megavoltage CT (MVCT) reduced interobserver variability.
METHODS: Two patients without hip prostheses and one patient (Patient 3) with hip prostheses were enrolled. Six radiation oncologists contoured prostate, rectum and bladder on kVCT (Patients 1 and 3), MRI (Patient 2) and MVCT images (Patient 3). MVCT was acquired with fine, normal and coarse modalities. Interobserver variability for each organ was analysed using conformity index (CI) and coefficient of variation (CV).
RESULTS: In patients without hip prostheses, CIs were higher in prostate contouring with MRI than with kVCT, indicating lower interobserver variability with MRI. Very slight variations were seen in rectum and bladder contouring. In the patient with hip prostheses (Patient 3), contouring on kVCT lowered CI and increased CV in the prostate, bladder and rectum. The differences were more marked in the prostate. Only fine modality MVCT reduced interobserver variability and only for the prostate.
CONCLUSION: Even though greater noise and less soft-tissue contrast increase contouring variability with MVCT than with kVCT, lack of artefacts on MVCT could provide better image definition by this modality in hip prosthesis patients in whom MRI is precluded. ADVANCES IN KNOWLEDGE: We recommend the fine modality MVCT for contouring hip prostheses patients.

Entities:  

Mesh:

Year:  2015        PMID: 26462970      PMCID: PMC4984939          DOI: 10.1259/bjr.20150509

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  19 in total

1.  Fast iterative algorithm for metal artifact reduction in X-ray CT.

Authors:  G Wang; T Frei; M W Vannier
Journal:  Acad Radiol       Date:  2000-08       Impact factor: 3.173

Review 2.  The expanding role of MRI in prostate cancer.

Authors:  Gillian Murphy; Masoom Haider; Sangeet Ghai; Boraiah Sreeharsha
Journal:  AJR Am J Roentgenol       Date:  2013-12       Impact factor: 3.959

3.  Feasibility of CBCT-based target and normal structure delineation in prostate cancer radiotherapy: multi-observer and image multi-modality study.

Authors:  Carola Lütgendorf-Caucig; Irina Fotina; Markus Stock; Richard Pötter; Gregor Goldner; Dietmar Georg
Journal:  Radiother Oncol       Date:  2010-12-20       Impact factor: 6.280

4.  Comparison of MRI with CT for the radiotherapy planning of prostate cancer: a feasibility study.

Authors:  V S Khoo; A R Padhani; S F Tanner; D J Finnigan; M O Leach; D P Dearnaley
Journal:  Br J Radiol       Date:  1999-06       Impact factor: 3.039

5.  Metal artefact reduction in MRI at both 1.5 and 3.0 T using slice encoding for metal artefact correction and view angle tilting.

Authors:  M Reichert; T Ai; J N Morelli; M Nittka; U Attenberger; V M Runge
Journal:  Br J Radiol       Date:  2015-01-23       Impact factor: 3.039

6.  Intensity-modulated radiation therapy with noncoplanar beams for treatment of prostate cancer in patients with bilateral hip prosthesis-a case study.

Authors:  Chris Brooks; Rex Min Cheung; Rajat J Kudchadker
Journal:  Med Dosim       Date:  2009-04-18       Impact factor: 1.482

7.  Reduction of postoperative CT artifacts of pelvic fractures by use of titanium implants.

Authors:  N A Ebraheim; R Coombs; J J Rusin; W T Jackson
Journal:  Orthopedics       Date:  1990-12       Impact factor: 1.390

8.  A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients.

Authors:  Darius Norkus; Agata Karklelyte; Benedikt Engels; Harijati Versmessen; Romas Griskevicius; Mark De Ridder; Guy Storme; Eduardas Aleknavicius; Ernestas Janulionis; Konstantinas Povilas Valuckas
Journal:  Radiat Oncol       Date:  2013-09-04       Impact factor: 3.481

9.  Optimization of tomotherapy treatment planning for patients with bilateral hip prostheses.

Authors:  David Chapman; Shaun Smith; Rob Barnett; Glenn Bauman; Slav Yartsev
Journal:  Radiat Oncol       Date:  2014-02-04       Impact factor: 3.481

10.  Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapy.

Authors:  Suresh Rana; ChihYao Cheng; Yuanshui Zheng; Wen Hsi; Omar Zeidan; Niek Schreuder; Carlos Vargas; Gary Larson
Journal:  J Appl Clin Med Phys       Date:  2014-05-08       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.